Nuclear Imaging

Molecular imaging, also called nuclear imaging, includes positron emission computed tomography (PET) and single photon emission computed tomography (SPECT) imaging. This section includes radiopharmaceuticals and tracersPET-CTSPECT-CT, and PET-MRI

Medrad Intego PET Infusion System, recall
News | Nuclear Imaging | January 12, 2017
January 12, 2017 — Bayer Healthcare has initiated a recall of all its Medrad Intego PET Infusion System Source...
Mirada Medical, RSNA 2016, XD:PACS, molecular imaging, nuclear imaging
Technology | PACS | January 06, 2017
January 6, 2017 — Mirada Medical showcased its latest ...
SPECT-CT, 3-D printing, University of Wurzburg, Germany, Johannes Tran-Gia, dosimetry calibration

SPECT/CT reconstructions and VOIs used for determination of calibration factors for the adult kidney filled with Lu-177 (A) and the corresponding sphere filled with I-131 (B). Credit: University of Würzburg

News | Medical 3-D Printing | January 06, 2017
January 6, 2017 — In nuclear medicine, the goal is to keep radiation exposure at a minimum, while obtaining quality...
News | Radiopharmaceuticals and Tracers | January 06, 2017
January 6, 2017 — New research demonstrates that a novel...
Nuclear cardiology, dose reduction, myocardial perfusion imaging
News | Nuclear Imaging | January 05, 2017
January 5, 2017 — Working in concert, the American Society of Nuclear Cardiology (ASNC), the Intersocietal...
metastatic colorectal cancer, mCRC, Sirtex, NCCN guidelines, Y-90 microspheres
News | Radiation Therapy | January 03, 2017
January 3, 2017 — Sirtex Medical Limited announced in December that SIR-Spheres Y-90 resin microspheres have been...
SNMMI Develops USP Recommendations for Compounded Sterile Radiopharmaceuticals
News | December 28, 2016
December 28, 2016 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has developed United States...
prostate, CT scan, Dave Fornell medical
News | Prostate Cancer | December 22, 2016
Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology firm focusing on cancer diagnostics and...
News | Prostate Cancer | December 14, 2016
December 14, 2016 — Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology firm focusing on...
News | Nuclear Imaging | December 12, 2016
Molecular Targeting Technologies, Inc. (MTTI) announces that response of colorectal cancer to treatment can be detected...
Numa, NumaStatus, radiation dose reporting software, RSNA 2016
News | Radiation Dose Management | December 08, 2016
December 8, 2016 — Numa introduced a new software application at the 2016 Annual Meeting of the Radiological Society of...
PET, F-18 florbetaben, cardiac amyloidosis, Princess Alexandria Hospital

In a pilot study, F-18-florbetaben PET imaging appeared promising for differentiating between cardiac amyloidosis and hypertensive heart disease. Image courtesy of W. Phillip Law/Princess Alexandra Hospital, Brisbane, Australia. 

News | Nuclear Imaging | December 06, 2016
December 6, 2016 — Researchers at Princess Alexandra Hospital, Brisbane, Australia, have demonstrated that cardiac...
xSPECT Quant technology, SPECT/CT, Symbia Intevo, Siemens Healthineers, RSNA 2016
News | SPECT Imaging | December 06, 2016
December 6, 2016 — At the 102nd Scientific Assembly and Annual Meeting of the Radiological Society of North America (...
prostate cancer, PET imaging, Johns Hopkins, Daniel Thorek, 11B6 antibody

Uptake of 89Zr-11B6 in the prostate of a transgenic mouse with prostate cancer. Image courtesy of Daniel Thorek

News | Prostate Cancer | November 30, 2016
November 30, 2016 — An international group of researchers report success in mice of a method of using...
Dilon Diagnostics, GE Healthcare, RSNA 2016, Discovery NM750b molecular breast imaging system, biopsy accessory, FDA clearance
Technology | Breast Imaging | November 28, 2016
November 28, 2016 — Dilon Diagnostics and GE Healthcare announced the U.S. Food and Drug Administration (FDA) clearance...
GE Healthcare, Dilon Diagnostics, North America distribution agreement, Discovery NM750b molecular breast imaging system
News | Women's Health | November 16, 2016
November 16, 2016 — Dilon Diagnostics and GE Healthcare announced the signing of an agreement for Dilon to be the...
Medic Vision, 2016 growth, RSNA, dose management, reporting, SafeCT
News | Radiation Dose Management | November 10, 2016
November 10, 2016 — Medic Vision Imaging Solutions Ltd. announced recently that the company has tripled its growth....
radiology outcomes

Graphic courtesy of Pixabay

Blog | Radiology Imaging | November 09, 2016
Much has been said about the potential of outcomes to change the practice of medicine. Through comparative studies,...
LumaGEM molecular breast imaging system, MBI, Gamma Medica, Henry Ford Health System, RSNA 2016
News | Breast Imaging | November 07, 2016
November 7, 2016 — Gamma Medica announced that Henry Ford Health System (Detroit) has purchased Gamma Medica’s LumaGEM...
Alzheimer's disease, early diagnosis, PET scans, imaging compound, Fluselenamyl

Researchers at Washington University School of Medicine in St. Louis have developed a chemical compound that detects the Alzheimer’s protein amyloid beta better than current FDA-approved agents. The compound potentially may be used in brain scans to identify people in the earliest stages of Alzheimer’s disease. In the image, the compound has passed from the bloodstream of a living mouse into its brain, where it is detected by a positron emission tomography (PET) scan. Arrows indicate clumps of amyloid beta. Credit Ping Yan and Jin-Moo Lee.

News | Radiopharmaceuticals and Tracers | November 02, 2016
November 2, 2016 — By the time unambiguous signs of memory loss and cognitive decline appear in people with Alzheimer’s...